Viralytics had a single product - Cavatak - and sold for $A500 million, seven times the current IMU market value of $A72 million. IMU has a pipeline of products, in various stages of development.
I'd have thought the best way to maximise shareholder value over the long term is to sell or license drugs/therapies as they progress through at least Stage 2 trials, while continuing development of the rest of the pipeline. Each deal should be able both to fund ongoing research, and might also allow IMU to pay shareholders a juicy special dividend.
While it's easy to start feeling just a bit of excitement, it could easily be a year or more before anything happens that gives the share price a kick along. As with all things biotech, patience is the key.
- Forums
- ASX - By Stock
- Leslie Chong Interview 3
Viralytics had a single product - Cavatak - and sold for $A500...
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.9¢ |
Change
0.002(5.41%) |
Mkt cap ! $386.7M |
Open | High | Low | Value | Volume |
3.6¢ | 4.0¢ | 3.5¢ | $1.163M | 31.27M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 2275218 | 3.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.9¢ | 196677 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
18 | 5665336 | 0.018 |
14 | 3997559 | 0.017 |
6 | 2974375 | 0.016 |
10 | 3219799 | 0.015 |
4 | 497500 | 0.014 |
Price($) | Vol. | No. |
---|---|---|
0.019 | 400000 | 2 |
0.020 | 5410946 | 12 |
0.021 | 8494780 | 17 |
0.022 | 8757253 | 13 |
0.023 | 4826614 | 8 |
Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |